Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Women with PCOS have higher levels of certain androgens, which are good at predicting excess hair growth.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Certain changes in the SHBG gene may increase the risk of PCOS in Iraqi women.

SHBG may be a useful early indicator and treatment target for PCOS.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

A new gene, JMJD1C, may affect testosterone levels in men.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

SHBG binding properties are unchanged in male liver cirrhosis patients.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Overweight women with PCOS are more likely to have excess male hormones.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Hirsutism causes significant psychological distress in women.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.